patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: New News
1
Apr 15, 2008 03:56PM

I hope some financial heavy hitters take notice of this.

From the Business Wire:

Pluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announced today that it has been chosen to present at the First Annual Israeli Presidential Conference termed "Facing Tomorrow", to be held on May 13-15, 2008 in Jerusalem.

The conference will focus on Jewish and Israeli contributions to humanity and will showcase 60 (for the 60th anniversary of the State of Israel), meticulously selected out of hundreds, inventions and innovations developed by Israeli scientists, researchers and inventors, that have the potential to revolutionize the future for Israel and the world community alike.

World leaders, artists, scientists and entrepreneurs will take part in the event. Confirmed conference participants include President George W. Bush, Former British Prime Minister Tony Blair; Former President of the USSR Mikhail Gorbachev; Former US Secretary of State Dr. Henry Kissinger; New York Times columnist Thomas L. Friedman; Chairman and CEO of News Corporation Rupert Murdoch; and Harvard Law Professor Alan Dershowitz.

Zami Aberman, Pluristem's President & CEO, stated: "Pluristem is pleased to be invited to this high level international conference to present its business and products in development to world-renowned business leaders, technology thought leaders and entrepreneurs."

Share
New Message
Please login to post a reply